Background COVID‐19 vaccinations in the United States are effective in preventing illness
and hospitalization yet concern over post‐vaccination venous thromboembolism (VTE) risk …

Background: Venous thromboembolism (VTE)—including deep vein thrombosis, pulmonary
embolism, and cerebral venous sinus thrombosis (CVST)—may occur early after vaccination …

Importance The actual risk of thrombotic events after Covid-19 vaccination is unknown.
Objective To evaluate the risk of thrombotic events after Covid-19 vaccination. Design …

Objectives Vaccination is one of the most effective measures to combat the COVID-19
pandemic. The main reason for severe acute respiratory syndrome coronavirus 2 (SARS …

Background Development of vaccines with high efficacy against COVID-19 disease has
ushered a new ray of hope in the fight against the pandemic. Thromboembolic events have …

Thrombo-embolic complications after Corona virus disease-19 (COVID-19) vaccination have
been previously reported. We aimed to study the coronary thrombo-embolic complications …

Objective To study the association between COVID-19 vaccination and the risk of post-
COVID-19 cardiac and thromboembolic complications. Methods We conducted a staggered …

Importance The incidence of arterial thromboembolism and venous thromboembolism in
persons with COVID-19 remains unclear. Objective To measure the 90-day risk of arterial …

COVID-19 vaccines are considered promising agents in the control of the pandemic.
Although their safety was assessed in randomised clinical trials, severe adverse events …

Background Thromboembolic and bleeding events after vaccination against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) are major public concerns leading to …